Dong-A ST (170900) Fundamentals 2026 — Revenue Analysis | SniperIQ
Dong-A ST (170900) is a KR-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of ₩331.7B, trading at ₩34400.00 on the KSC. This SniperIQ fundamentals page covers Dong-A ST's valuation, profitability (net margin -2.1%), revenue (₩808.8B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Dong-A ST's market cap?
Dong-A ST (170900) has a market capitalization of approximately ₩331.7B, trading at ₩34400.00 on the KSC. Market cap moves with the live share price.
What is Dong-A ST's P/E ratio?
Dong-A ST's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Dong-A ST?
Dong-A ST runs a net profit margin of -2.1%, a gross margin of 43.2%, and an operating margin of 1.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Dong-A ST generate?
Dong-A ST reported revenue of ₩808.8B for fiscal year 2025, with net income of -₩28.6B and earnings per share (EPS) of -2970.54. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Dong-A ST pay a dividend?
Dong-A ST offers a trailing dividend yield of about 2.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Dong-A ST financially healthy?
Dong-A ST carries a debt-to-equity ratio of 0.75x and a current ratio of 1.50x, with a market beta of 0.40. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Dong-A ST a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Dong-A ST (170900) the key facts are: market cap ₩331.7B, revenue ₩808.8B, 52-week range 31600-56380.953. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Dong-A ST's full fundamentals live
Get Dong-A ST's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.